The short version
Just 2 companies supply this market — thin enough that a single exit would be felt immediately.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Solifenacin Succinate
solifenacin succiate · SOLIFENACIN SUCCINATE 5 mg/1 · Tablet, Film Coated · Oral · Bostal LLC
NDC 35561-0285-00 · 256410 TABLET, FILM COATED in 1 BOX · ANDA · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Regulatory
- Application
- ANDA210281
- TE code
- AB
- Approval date
- May 20, 2019
- Patents / exclusivity
- None on file
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of solifenacin succiate (Tablet, Film Coated)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| AvKARE | SOLIFENACIN SUCCINATE 5 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Bostal LLC | SOLIFENACIN SUCCINATE 5 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Solifenacin Succinate — NDC 35561-0285-00," retrieved September 3, 2026, https://drugdashboards.com/drug/35561028500.
Free to cite with attribution — see how the data is put together.